CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Exercise or conversion Director acquired 257 shares (option exercise)
- 4 Exercise or conversion Director acquired 257 shares (option exercise)
- 4 Exercise or conversion Director acquired 101 shares (option exercise)
- 4 Exercise or conversion Director acquired 339 shares (option exercise)
- 4 Exercise or conversion Director acquired 257 shares (option exercise)
- 4 Exercise or conversion Director acquired 158 shares (option exercise)
- 4 Grant or award Director acquired 43 shares (grant or award)
- 4 Exercise or conversion EVP, GC & Corporate Secretary acquired 197 shares (option exercise)
- 4 Open-market sale Executive Vice President sold 1,758 shares at $634.57 ($1,115,577)
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 23,326 shares at an average $657.55 ($15,338,081)
- 4 Open-market sale Executive Vice President sold 2,693 shares at $661.54 ($1,781,531)
- 4 Open-market sale Executive Vice President sold 5,371 shares at an average $627.38 ($3,369,666)
- 4 Open-market sale Director sold 1,464 shares at an average $628.62 ($920,293)
- 4 Shares withheld for taxes EVP, GC & Corporate Secretary gave up 251 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 302 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 876 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 915 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 221 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 178 shares (to pay taxes)
Page 2 of 74 · 1,466 filings